Aaron Pelta
Corporate Officer/Principal at MORPHIC HOLDING, INC.
Profile
Aaron Pelta's career history includes former positions as Vice President-Business Development & Transactions at AMAG Pharmaceuticals, Inc. in 2015, and Vice President-Business Development at X4 Pharmaceuticals (Austria) GmbH from 2016 to 2019.
He also holds a current position as Senior Vice President-Business & Development at Morphic Holding, Inc. starting in 2022.
Mr. Pelta obtained an undergraduate degree from Tufts University in 1996 and an MBA from Tuck School of Business at Dartmouth in 2002.
Aaron Pelta active positions
| Companies | Position | Start |
|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01/01/2019 |
Former positions of Aaron Pelta
| Companies | Position | End |
|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01/03/2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2015 |
Training of Aaron Pelta
| Tufts University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Private companies | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Stock Market
- Insiders
- Aaron Pelta